期刊
NATURE REVIEWS CARDIOLOGY
卷 11, 期 11, 页码 629-631出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/nrcardio.2014.132
关键词
-
Over the past decade, we have witnessed the unparalleled success of statins to treat dyslipidaemia. Target identification by Mendelian randomization, human monoclonal antibodies, gene therapy, RNA-based targets, and atherogenic lipoproteins other than LDL cholesterol have fuelled intense development efforts that might bear fruit in the very near future.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据